Healthcare -
Biotechnology - NASDAQ - US
$ 43.33
-0.161 %
$ 4 B
Market Cap
-6.82
P/E
RARE - NET CHANGE IN CASH
Net Change in Cash RARE - Ultragenyx Pharmaceutical Inc.
81.8 M
LAST VALUE
48.20%
2 YEAR CAGR
45.64%
5 YEAR CAGR
11.75%
10 YEAR CAGR